Api, Pharmaceutical Intermediates, Linagliptin, Azilsartan, Avanafil, Everoliums, Alogliptin, Monobenzone, Teneligliptin, Rifabutin, Adefovir Dipivoxil, Rhododendrol
New Products From This Supplier
We have a widespread assortment of available. We are rolling out in global marketplace with economical rates for and api, pharmaceutical intermediates, linagliptin, azilsartan, avanafil, everoliums, alogliptin, monobenzone, teneligliptin, rifabutin, adefovir dipivoxil, rhododendrol products produced in china. Our company can offer good quality anti infective drugs & medicines and many other china api, pharmaceutical intermediates, linagliptin, azilsartan, avanafil, everoliums, alogliptin, monobenzone, teneligliptin, rifabutin, adefovir dipivoxil, rhododendrol products, as they are a famous manufacturer. Our company is a recognized company in china that is exporting globally.
|
Dosage Form |
Injection |
Business Nature
Manufacturer
No. Employees
11 - 50 People
Year Established
2004
Annual Turnover
Approx 0.8 Million US Dollar
Country/Region
Chengdu, China
Main Products
Api...
Legal Status
Own Lisence
Payment Terms
Bank wire (T/T), Doc Against Payment (D/P), Western Union (WU), Cash
Chengdu Yuyang High tech Development Co., ltd is one of the recognized Manufacturer creating Medical & Healthcare and many more China API, pharmaceutical intermediates, Linagliptin, Azilsartan, Avanafil, Everoliums, Alogliptin, Monobenzone, Teneligliptin, Rifabutin, Adefovir dipivoxil, Rhododendrol products. The branch of Chengdu Yuyang High tech Development Co., ltd is situated in Chengdu Sichuan China. Chengdu Yuyang High tech Development Co., ltd is a well-known company in China that is operating all over the world. Chengdu Yuyang High tech Development Co., ltd Description Name: June Xiao
Address: Chengdu Sichuan
Country: China
Main Products: API, pharmaceutical intermediates, Linagliptin, Azilsartan, Avanafil, Everoliums, Alogliptin, Monobenzone, Teneligliptin, Rifabutin, Adefovir dipivoxil, Rhododendrol
Year Established: 2004
Export Focus: Australia, Canada, Germany, South Korea, United Kingdom
Estimated Employees: 501 - 1000 People
Registered Capital: Below US$1 Million
Ownership Status: Private Owner
Export Percentage: 41% - 50%
Factory Size: 1, 000-3, 000 square meters
Production Lines: 1
Research Team Size: 51 - 100 People
Contract Services: Buyer Label Offered
